Institute Of Medical Biology, Chinese Academy Of Medical Sciences

This study tests a new version of the Tdap vaccine (which protects against tetanus, diphtheria, and whooping cough) that has reduced antigens. The goal is to see if it is safe and triggers a strong immune response in people aged 6 and up. Around 660 volunteers will receive either…

This early-stage trial tests a new vaccine designed to protect against hand, foot, and mouth disease caused by two common viruses. About 144 healthy volunteers aged 6 months to 59 years will receive either the vaccine or a placebo. The main goal is to check safety and see how wel…